|
MED-EL plans expansion in India to restore hearing abilities among deaf
|
|
Our Bureau, Mumbai
April 01 , 2017
|
|
|
MED-EL India, the Indian subsidiary of the global leading provider of
hearing implant systems MED-EL, known for developing innovative products
to help patients overcome hearing loss worldwide, announced the
“Roadmap and Opportunities for the growth of hearing aid technology and
impairment treatments in India in the next decade’ basis an industry
conclave held in NCR.
The conclave was attended by MED-EL global
chief executive officer Dr. Ingeborg Hochmair and other healthcare
professionals, surgeons and industry experts to address the needs of the
hearing impaired in India.
Tejinder Singh, director at MED-EL
India said, “In India, it is estimated that up to 8.8% of the population
suffers from hearing loss with approximately 3.8 million children
waiting for cochlear implants. If children are implanted early with a
cochlear implant, they can go on to lead a normal life and develop
through the education system. Our company vision is to overcome hearing
loss as a barrier to communication and quality of life. It is our
endeavour at MED-EL to provide a service that is reliable, trustworthy,
and offers the very latest in technology to the many millions of Indians
who can benefit from a cochlear implant.”
Prof. (Dr.) J.M. Hans,
Padmashree awardee and renowned surgeon said “There are more solutions
available than ever before to restore the gift of hearing to the Indian
people who suffer from various types of hearing loss. Early implantation
of children with hearing loss allows them to develop listening and
speaking skills and increase their opportunities for the future.”
The
number of cochlear implantations in India is growing rapidly, with
investments from the Government and the increased demand from the Indian
population. MED-EL has been a principal supplier for cochlear implants
and is supporting government sponsored cochlear implant programs in
several states like Tamil Nadu, Kerala, Delhi, Chhattisgarh, Assam,
Gujarat and Madhya Pradesh; to name a few. Through the Indian
subsidiary, company continues to expand and support 100+ clinics in 45+
major cities in India, Sri Lanka, Nepal and Bangladesh. MED-EL is
helping to drive this industry with long-term implant solutions and
support that can bring major economic benefits to the country. MED-EL
India is positioned not only as a supplier but as a long-term service
provider for the entirety of the implant cycle.
Tejinder Singh,
Director, MED-EL India added, “At MED-EL India, we have a young,
enthusiastic and professionally competent team. By working closely
together with our healthcare partners and Government we can really make
life changing differences for the millions of Indian affected with
hearing loss and to the Indian economy in the next 10 years.”
MED-EL
has been represented in India since the past 25 years (1992) but has a
direct presence through a 100% owned subsidiary operation established in
India since 2006 (10 years) and provides the widest range of hearing
solutions to treat numerous degrees of hearing loss such as conductive,
sensorineural, mixed and neural hearing loss. The company’s solutions
are distinguished by performance, ease of use and reliability.
Austria-based
MED-EL Medical Electronics is a leading provider of hearing implant
systems with 29 subsidiaries worldwide. The family-owned business is one
of the pioneers in the industry. The two Austrian scientists Ingeborg
and Erwin Hochmair developed the world’s first
microelectronic-multichannel Cochlear-Implant in 1977. The cochlear
implant was and remains the first replacement of a human sense, the
sense of hearing. In 1990 they laid the foundation for the successful
growth of the company when they hired their first employees. To date,
the company has grown to more than 1700 employees around the world.
Today
MED-EL offers the widest range of implantable solutions worldwide to
treat various degrees of hearing loss: cochlear and middle ear implant
systems, EAS combined Electric Acoustic Stimulation (EAS) hearing
implant system and auditory brainstem implants as well as the world´s
first active bone conduction implant.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|